Armed with $100M grant, El­e­vate­Bio looks to cre­ate bio­man­u­fac­tur­ing cen­ter with the Uni­ver­si­ty of Pitts­burgh

While Pitts­burgh has a rich man­u­fac­tur­ing his­to­ry, one biotech is look­ing to make the city more than just a steel pow­er­house.

David Hal­lal’s El­e­vate­Bio, which has man­aged to build out an im­pres­sive war chest of funds over the past few years, will see its lat­est move part­ner­ing with a uni­ver­si­ty to cre­ate a bio­man­u­fac­tur­ing site.

In an an­nounce­ment Thurs­day, El­e­vate­Bio and the Uni­ver­si­ty of Pitts­burgh say they’ve signed a 30-year deal for El­e­vate­Bio to man­u­fac­ture cell and gene ther­a­pies in Pitts­burgh. The agree­ment will have El­e­vate­Bio lo­cate its Base­Camp and GMP man­u­fac­tur­ing fa­cil­i­ties in the city, with the site even­tu­al­ly run­ning gene edit­ing, in­duced pluripo­tent stem cell (iP­SC) and cell, vec­tor and pro­tein en­gi­neer­ing ef­forts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER